Advertisement
Australia markets open in 4 hours 52 minutes
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6426
    -0.0011 (-0.17%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    82.84
    +0.15 (+0.18%)
     
  • GOLD

    2,395.90
    +7.50 (+0.31%)
     
  • Bitcoin AUD

    98,750.42
    +3,409.13 (+3.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Coloplast A/S - Announcement no. 11/2021 - Decisions at the Annual General Meeting 2021

Today, 2 December 2021, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted:

  • The annual report for the financial year 2020/21 was approved.

  • Distribution of year-end dividend of DKK 14.00 per share of nominally DKK 1 was approved. In addition to the interim dividend of DKK 5.00 per share of nominally DKK 1 paid out in connection with Coloplast A/S’ half-year result, this brings the total dividend paid for the year to DKK 19.00 per share of nominally DKK 1.

  • The remuneration report for the financial year 2020/21 was approved.

  • The remuneration of the members of the Board of Directors for the financial year 2021/22 was approved.

  • The updated remuneration policy as proposed by the Board of Directors was approved.

  • Lars Søren Rasmussen, Niels Peter Louis-Hansen, Carsten Hellmann, Jette Nygaard-Andersen and Marianne Wiinholt were re-elected to the Board of Directors. Annette Brüls was elected as a new member of the Board of Directors.

  • PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab was re-elected.

Immediately after the Annual General Meeting, the Board of Directors elected Lars Søren Rasmussen as Chairman and Niels Peter Louis-Hansen as Deputy Chairman. In addition to the members of the Board of Directors elected at the Annual General Meeting, the Board of Directors consists of three members elected by the employees: Thomas Barfod, Nikolaj Kyhe Gundersen and Roland Vendelbo Pedersen.


For further information, please contact


Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

ADVERTISEMENT

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com

Press and the media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com


This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-12.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments

Attachment